Cortisone

Cortisone is a naturally occurring glucocorticoid hormone that serves as the foundation for understanding corticosteroid medications used in feline medicine. As a synthetic pharmaceutical preparation, cortisone belongs to the class of short-acting corticosteroids and is considered one of the less potent agents in this drug category. While cortisone itself is used less frequently in modern veterinary practice compared to more potent alternatives like prednisolone or dexamethasone, it remains an important medication for specific applications and provides insight into the broader category of corticosteroid therapy in cats. Understanding cortisone helps pet owners comprehend the mechanisms and considerations that apply to all corticosteroid medications their cats may receive.

The mechanism of action of cortisone involves its conversion to the active form cortisol (hydrocortisone) within the body, which then binds to glucocorticoid receptors to produce anti-inflammatory and immunomodulatory effects. This conversion requirement means cortisone acts as a prodrug, requiring metabolic activation before exerting its therapeutic effects. Once converted, the active hormone influences gene expression in target cells, reducing the production of inflammatory mediators, stabilizing cell membranes, and modulating immune cell function. These effects collectively reduce inflammation, suppress inappropriate immune responses, and provide symptomatic relief across various conditions affecting cats.

Cortisone is available in oral tablet formulations and injectable preparations, though its use in cats is limited compared to other corticosteroids that offer more predictable potency and longer duration of action. When used, oral cortisone is typically administered according to a specific schedule determined by the veterinarian based on the condition being treated. The short duration of action requires more frequent dosing compared to longer-acting alternatives, which may be advantageous when brief corticosteroid effect is desired or when gradual tapering is being implemented. The relatively lower potency of cortisone can also be beneficial in situations where milder anti-inflammatory effect is appropriate.

As with all corticosteroid medications, cortisone use in cats requires veterinary supervision to ensure appropriate diagnosis, proper dosing, and monitoring for potential adverse effects. The benefits and risks of corticosteroid therapy must be carefully balanced for each individual patient, considering the specific condition being treated, the cat's overall health status, and the anticipated treatment duration. Pet owners should understand that while cortisone and related corticosteroids can provide significant therapeutic benefits, these medications also carry potential for side effects that necessitate careful monitoring and adherence to veterinary instructions throughout the treatment period.

Cortisone and its derivatives are used in feline medicine primarily for their anti-inflammatory and immunosuppressive properties, addressing a variety of conditions where these effects provide therapeutic benefit. While cortisone itself is less commonly prescribed than more potent corticosteroids, understanding its applications illuminates the broader uses of this medication class in cats. The primary indications involve managing inflammatory conditions, allergic diseases, certain autoimmune disorders, and providing replacement therapy in cases of adrenal insufficiency where the body cannot produce adequate natural corticosteroids.

Inflammatory conditions affecting various organ systems may be treated with corticosteroids including cortisone preparations. Skin inflammation from allergies, immune-mediated skin diseases, or other causes often responds to corticosteroid therapy, with medications reducing the redness, swelling, and itching that cause patient discomfort. Inflammatory bowel disease, a relatively common condition in cats causing gastrointestinal symptoms, frequently requires corticosteroid therapy as part of the management strategy. Respiratory inflammation, including that associated with feline asthma, may also be addressed with systemic or inhaled corticosteroids depending on the severity and chronicity of the condition.

Allergic conditions represent one of the most frequent applications for corticosteroid therapy in cats. Flea allergy dermatitis, environmental allergies (atopic dermatitis), and food allergies can all cause significant skin inflammation and pruritus that corticosteroids effectively manage. While addressing the underlying allergen is ideal, corticosteroids provide symptomatic relief that improves quality of life during diagnostic investigations or when complete allergen avoidance is not achievable. The anti-inflammatory effects reduce the itch-scratch cycle that perpetuates skin damage and secondary infections in allergic cats.

Immune-mediated diseases where the immune system inappropriately attacks the body's own tissues may require corticosteroid therapy to suppress the harmful immune response. Conditions such as immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and pemphigus complex skin diseases often necessitate immunosuppressive doses of corticosteroids. While more potent corticosteroids are typically selected for these serious conditions, understanding the immunosuppressive mechanism of cortisone-class medications helps pet owners comprehend the treatment approach for these challenging diseases.

Adrenal insufficiency, also known as hypoadrenocorticism or Addison's disease, represents a condition where replacement corticosteroid therapy is genuinely necessary because the cat's adrenal glands cannot produce adequate amounts of natural hormones. While this condition is rare in cats compared to dogs, affected individuals require lifelong hormone replacement including glucocorticoids. Cortisone or related preparations may be used as part of the replacement therapy regimen, providing the hormone supplementation that the body cannot produce on its own. Treatment of adrenal insufficiency differs from anti-inflammatory use in that it aims to restore normal physiological hormone levels rather than achieve pharmacological immunosuppression.

Cortisone dosing in feline patients must be determined by a veterinarian based on the specific indication, the severity of the condition being treated, and individual patient factors including body weight and overall health status. Corticosteroid dosing is not standardized across conditions, with anti-inflammatory doses differing substantially from immunosuppressive doses or physiological replacement doses for adrenal insufficiency. The relatively lower potency of cortisone compared to other corticosteroids means that higher milligram doses may be required to achieve equivalent effects, and this factor influences the veterinarian's selection of which corticosteroid to prescribe for a given situation.

Oral cortisone tablets are typically administered according to a schedule determined by the veterinarian, which may range from once daily to multiple times daily depending on the condition and treatment phase. The short duration of action of cortisone means that divided daily doses may be needed for conditions requiring continuous anti-inflammatory effect. Administration with food is generally recommended to reduce the potential for gastrointestinal irritation, and giving the medication at consistent times each day helps maintain stable drug levels. Pet owners should follow the prescribed schedule carefully, as erratic dosing can reduce therapeutic effectiveness and complicate monitoring of the cat's response.

Treatment duration with cortisone varies considerably based on the underlying condition. Acute inflammatory conditions may require only brief treatment courses lasting days to a few weeks, while chronic conditions might necessitate longer-term therapy. For conditions requiring extended corticosteroid treatment, veterinarians often transition patients to longer-acting corticosteroids that allow less frequent dosing. When cortisone therapy extends beyond acute treatment, careful tapering rather than abrupt discontinuation is typically employed to allow the adrenal glands to resume normal hormone production after being suppressed by exogenous corticosteroid administration.

Proper administration technique helps ensure effective treatment and reduces the likelihood of complications. Tablets should be given whole unless the veterinarian specifically instructs that they may be divided or crushed. If the cat resists taking tablets directly, they may be hidden in a small amount of food or a commercial pill pocket, ensuring the entire dose is consumed. Liquid formulations, when available, should be measured precisely using the provided measuring device and administered directly into the mouth or mixed with a small amount of food. Injectable cortisone is administered by veterinary staff and does not require home administration.

When a dose of cortisone is missed, pet owners should give the missed dose as soon as they remember, unless the next scheduled dose is approaching. If it is nearly time for the regular dose, the missed dose should be skipped and the normal schedule resumed. Doses should never be doubled to compensate for missed administrations, as this increases the risk of side effects without providing additional therapeutic benefit. Consistent dosing is important for optimal treatment outcomes, and pet owners who frequently miss doses should discuss the situation with their veterinarian to determine whether an alternative medication or dosing schedule would be more practical.

Treatment completion and proper discontinuation require adherence to veterinary instructions regarding tapering schedules. Abrupt cessation of corticosteroid therapy after extended use can result in adrenal insufficiency because the body's natural corticosteroid production may be suppressed during treatment. Veterinarians design tapering schedules that gradually reduce the dose over days to weeks, allowing the adrenal glands to resume function. Even when the cat appears fully recovered, the tapering schedule should be followed as prescribed. If problems arise during tapering, such as recurrence of symptoms, pet owners should contact their veterinarian rather than adjusting the dose independently.

Cortisone and related corticosteroids can cause various side effects in cats, though the lower potency of cortisone compared to some alternatives may result in less pronounced adverse effects at equivalent therapeutic doses. Cats are generally considered more resistant to certain corticosteroid side effects compared to dogs, but adverse reactions can still occur and warrant monitoring throughout treatment. Understanding potential side effects helps pet owners recognize concerning signs early and maintain appropriate communication with their veterinary team regarding any changes in their cat's condition during treatment.

Common side effects associated with corticosteroid use in cats include increased thirst and urination, clinically termed polydipsia and polyuria, resulting from the drugs' effects on kidney function and fluid regulation. Many cats receiving corticosteroids also experience increased appetite, which can lead to weight gain if food intake is not managed appropriately. These effects are generally dose-dependent and typically resolve when the medication is discontinued or reduced. Some cats may exhibit behavioral changes including restlessness, irritability, or altered activity levels. Gastrointestinal effects such as stomach upset are possible, and giving the medication with food may help reduce this risk.

More significant side effects may develop with prolonged corticosteroid use or high doses. Metabolic changes including elevated blood glucose can occur, potentially leading to or worsening diabetes mellitus in susceptible cats. Cats receiving extended corticosteroid therapy should be monitored for signs of diabetes such as dramatically increased thirst and urination, weight loss despite good appetite, and general weakness. Immune suppression represents an important concern, as the same property that makes corticosteroids useful for autoimmune conditions also increases susceptibility to infections. Cats on chronic corticosteroid therapy may be more vulnerable to bacterial, viral, and fungal infections, and the anti-inflammatory effects may mask early signs of developing infections.

Skin and coat changes may occur with long-term corticosteroid administration, including thinning of the skin, delayed wound healing, and changes in hair coat quality. Some cats develop a fragile skin condition that increases vulnerability to tears and injuries. These effects are generally reversible after treatment discontinuation, though resolution may take weeks to months. The development of iatrogenic Cushing's syndrome, characterized by pot-bellied appearance, muscle wasting, and skin changes, is possible with chronic high-dose corticosteroid therapy but is less common in cats than in dogs.

Serious side effects requiring immediate veterinary attention include signs of severe infection such as high fever, profound lethargy, or respiratory distress. Severe gastrointestinal signs including vomiting blood or passing bloody or black tarry stools could indicate gastric ulceration, a serious complication requiring urgent care. Development of diabetic crisis with weakness, vomiting, and altered consciousness constitutes an emergency. Any sudden changes in the cat's neurological status, significant decline in overall condition, or symptoms that concern the pet owner warrant prompt communication with the veterinary team. Regular monitoring appointments allow the veterinarian to assess for developing problems and adjust the treatment plan as needed.

Cortisone is contraindicated in cats with known hypersensitivity to the medication or other corticosteroids. While true allergic reactions to corticosteroids are rare, any cat that has experienced previous adverse reactions to corticosteroid administration should be carefully evaluated before receiving cortisone or related medications. Pet owners should inform the veterinary team of any previous reactions to medications, as this history guides treatment decisions and may indicate the need for alternative therapeutic approaches. Documentation of drug sensitivities helps ensure safe medication selection throughout the cat's life.

Systemic fungal infections represent an important contraindication to cortisone and other corticosteroid use. The immunosuppressive effects of these medications can allow fungal organisms to proliferate, potentially converting localized infections into dangerous systemic disease. Cats with diagnosed or suspected systemic fungal infections should not receive corticosteroids until the infection is adequately controlled with antifungal therapy. Similarly, active viral infections may worsen with corticosteroid administration, as immune suppression facilitates viral replication. When corticosteroid therapy is necessary in cats with concurrent infections, appropriate antimicrobial treatment and careful monitoring are essential.

Cats with diabetes mellitus require careful consideration before cortisone administration due to the hyperglycemic effects of corticosteroids. These medications promote glucose production and reduce insulin sensitivity, potentially destabilizing diabetic control or precipitating diabetic crises in cats with existing diabetes. Corticosteroids may also induce diabetes in predisposed cats. When corticosteroid therapy is deemed essential for a diabetic cat, enhanced glucose monitoring and insulin dose adjustments are typically required. The veterinarian weighs the necessity of corticosteroid therapy against the risks of diabetic complications, and alternative treatments may be preferred when available.

Other conditions warranting caution or contraindicating corticosteroid use include gastrointestinal ulceration or history of bleeding ulcers, congestive heart failure where fluid retention could be dangerous, severe osteoporosis, and certain other systemic conditions. Pregnant cats should generally avoid corticosteroid therapy, particularly during early pregnancy, as these medications can affect fetal development and potentially cause pregnancy loss. Nursing mothers warrant consideration regarding drug passage into milk. The veterinarian evaluates each cat's complete medical history and current conditions to determine whether cortisone is appropriate, selecting alternative treatments when contraindications exist or when the risk-benefit assessment does not favor corticosteroid use.

Providing complete information about all medications, supplements, and treatments your cat receives is essential when cortisone therapy is being considered or administered. Drug interactions can significantly impact the safety and effectiveness of corticosteroid treatment, potentially increasing adverse effect risk or reducing therapeutic benefit. The veterinary team requires comprehensive medication history to make informed treatment decisions and to anticipate potential interaction effects. This disclosure should include all prescription medications, over-the-counter products, supplements, and any treatments being administered by other veterinary providers.

Non-steroidal anti-inflammatory drugs represent a critically important interaction concern with cortisone and other corticosteroids. Concurrent use of NSAIDs and corticosteroids substantially increases the risk of gastrointestinal ulceration and bleeding, a potentially life-threatening complication. Veterinarians typically avoid prescribing these drug classes simultaneously, and when both are necessary, gastroprotective medications and careful monitoring are implemented. Pet owners should never give over-the-counter pain relievers such as aspirin, ibuprofen, or naproxen to cats receiving corticosteroids without explicit veterinary instruction, as these products are NSAIDs that could cause serious harm.

Cortisone may interact with various other medication classes including insulin and oral diabetic medications, certain diuretics, cardiac medications, and some antibiotics and antifungal agents. The hyperglycemic effects of corticosteroids can counteract diabetic medications, requiring dose adjustments in cats with diabetes. Certain diuretics used in combination with corticosteroids may enhance potassium loss, potentially causing dangerous electrolyte imbalances. Drug interactions may affect how quickly cortisone is metabolized and eliminated from the body, potentially altering its effectiveness or increasing toxicity risk.

Herbal supplements and nutraceuticals may also interact with corticosteroid therapy, though specific interaction data in cats is often limited. Products with immunomodulating effects could theoretically interact with cortisone, either enhancing or counteracting the medication's effects. Licorice root contains compounds that can potentiate corticosteroid effects and should be used cautiously if at all during treatment. Pet owners should disclose all supplement and nutraceutical use to their veterinarian, who can provide guidance on which products to continue, discontinue, or adjust during cortisone therapy. Monitoring for unexpected effects or changes in treatment response helps identify potential interactions that may not have been anticipated.

General precautions for cortisone use in cats emphasize the importance of accurate diagnosis before initiating corticosteroid therapy, appropriate dosing, and careful monitoring throughout treatment. Because corticosteroids can mask signs of infection and other conditions, proper diagnosis ensures that underlying problems are not overlooked while symptoms are suppressed. Veterinarians confirm diagnoses through appropriate testing before prescribing cortisone for conditions where corticosteroid therapy is indicated. Accurate weight measurement is essential for proper dosing calculations, and pet owners should inform the veterinary team of any significant weight changes during treatment.

While no specific breed-related sensitivities to cortisone have been definitively established in cats, individual variation in corticosteroid response exists across the feline population. Certain breeds including Burmese cats have higher prevalence of diabetes mellitus and may be at increased risk for corticosteroid-induced or corticosteroid-worsened diabetes. Similarly, breeds with predispositions to heart disease may warrant additional consideration regarding fluid retention effects of corticosteroids. The veterinary team monitors each patient individually and adjusts treatment based on the specific cat's response, regardless of breed.

Environmental and handling precautions for cortisone are generally minimal for pet owners. Medications should be stored safely away from children and other pets who might accidentally ingest them. When handling the medication, routine hygiene practices are sufficient, as cortisone does not require special protective measures for typical handling. In multi-pet households, ensuring that only the intended patient receives the medication prevents unnecessary drug exposure to healthy animals. Pet owners with significant concerns about handling corticosteroids should discuss these with their veterinarian.

Monitoring during cortisone treatment includes regular observation for therapeutic response and emergence of side effects. Pet owners should watch for improvement in the treated condition while also noting common side effects such as increased thirst, urination, and appetite. Signs of potential complications including excessive lethargy, vomiting, diarrhea, signs suggestive of infection, or dramatic changes in thirst and urination patterns warrant prompt veterinary communication. Cats receiving extended corticosteroid therapy benefit from periodic veterinary examinations and blood work to monitor overall health and detect early signs of metabolic complications.

Special population considerations apply to geriatric cats, young kittens, and cats with concurrent medical conditions. Older cats may have reduced liver and kidney function affecting drug metabolism, pre-existing conditions that corticosteroids could worsen, and greater vulnerability to certain side effects. Kittens require careful dose calculation and consideration of potential effects on growth and development. Cats with chronic kidney disease, heart disease, diabetes, or other ongoing conditions need individualized evaluation and enhanced monitoring protocols. The veterinary team considers all relevant patient factors when prescribing cortisone and establishing the monitoring plan.

Cortisone preparations should be stored according to the manufacturer's labeled instructions, which typically specify controlled room temperature storage away from excessive heat, moisture, and direct light exposure. Most oral cortisone formulations remain stable when stored between 15 and 30 degrees Celsius in their original containers with caps tightly secured. Medications should be kept in areas with stable temperatures, avoiding locations near heating vents, sunny windows, appliances that generate heat, or areas with high humidity such as bathrooms. The original container provides optimal protection and maintains important information including expiration dates and dosing instructions.

Different cortisone preparations may have specific storage considerations. Tablet formulations generally have longer shelf lives when properly stored compared to some liquid preparations. Injectable formulations, which are typically maintained at veterinary facilities, may have different storage requirements and are handled by veterinary staff. Pet owners should note the expiration date when receiving the medication and ensure they have adequate supply for the prescribed treatment duration. Signs of medication degradation may include changes in tablet appearance, unusual odors, or changes in liquid consistency, and any suspicious changes should prompt consultation with the veterinarian before continued use.

Safe handling and disposal practices help protect household members and the environment. Cortisone medications should be stored in locations inaccessible to children, pets, and other household members who might accidentally ingest them. Child-resistant containers should be used and properly secured after each use. Accidental ingestion of corticosteroids by children or pets should be treated as a potential poisoning event, with appropriate medical or veterinary attention sought. Unused or expired cortisone should be disposed of properly according to local pharmaceutical waste guidelines, which may include drug take-back programs, pharmacy disposal options, or specific home disposal instructions provided by veterinary or public health authorities. Medications should not be flushed down toilets or drains unless specifically instructed by disposal guidelines.

Cats of all breeds can generally receive cortisone therapy when appropriately indicated, as no specific breed-related contraindications have been definitively established for corticosteroid use in felines. The decision to use cortisone is based primarily on the medical condition being treated, the individual cat's overall health status, and the expected therapeutic benefits relative to potential risks. However, awareness of certain breed predispositions helps veterinarians provide optimal care through appropriate monitoring and treatment modifications when needed.

Certain breed predispositions to metabolic conditions may influence corticosteroid therapy decisions. Burmese cats have notably higher incidence of diabetes mellitus compared to other breeds, and corticosteroid administration carries elevated risk of inducing or worsening diabetic conditions in these cats. Tonkinese cats, closely related to Burmese, may share similar predispositions. While these predispositions do not absolutely contraindicate cortisone use, they inform the risk-benefit analysis and may indicate need for enhanced monitoring of blood glucose during treatment. Veterinarians consider these factors when designing treatment plans for cats of susceptible breeds.

Body size considerations affect cortisone dosing across the feline population. Larger cat breeds such as Maine Coons, Norwegian Forest Cats, and Ragdolls may require higher total doses based on their greater body mass, while smaller cats and Oriental breeds receive proportionally adjusted amounts. Accurate weight measurement ensures proper dosing regardless of breed size. Very small cats may present dosing challenges if available tablet sizes do not allow precise dose division, potentially requiring compounded preparations or alternative corticosteroid selections to achieve accurate dosing.

Age-related factors often have greater influence on cortisone therapy than breed considerations. Geriatric cats of any breed commonly have diminished organ function affecting drug metabolism, may have pre-existing conditions including diabetes or kidney disease that corticosteroids could worsen, and may be more susceptible to certain side effects. Kittens require careful dose calculation and consideration of potential effects on growth and development. The veterinary team evaluates each patient's individual circumstances, incorporating both breed-related predispositions and age-related factors into treatment planning and monitoring protocols. Individual variation within breeds means that each cat's response to treatment must be monitored regardless of breed expectations.

Other corticosteroids used in feline medicine include prednisolone, which is often considered the first-choice oral corticosteroid for cats due to superior absorption and well-established dosing guidelines. Cats cannot efficiently convert prednisone to its active form prednisolone as dogs and humans do, so prednisolone is preferred when oral corticosteroid therapy is indicated. Dexamethasone and betamethasone are potent, long-acting corticosteroids used when extended duration of effect is desired or for specific clinical applications. Hydrocortisone, closely related to cortisone as the active form cortisol, is available in various formulations including topical preparations for localized treatment. The selection among corticosteroids depends on the condition being treated, desired potency and duration of action, available formulations, and individual patient factors.

Alternative medications may be considered for conditions commonly treated with corticosteroids when these drugs are contraindicated or when corticosteroid-sparing approaches are desired. Cyclosporine is an immunomodulating medication used for various allergic and immune-mediated conditions, potentially allowing reduced corticosteroid doses or replacement of corticosteroids in some cases. Antihistamines, while often less effective than corticosteroids for allergic conditions in cats, may provide supportive therapy. For specific conditions like inflammatory bowel disease, dietary modification and other targeted therapies may complement or partially substitute for corticosteroid therapy. The veterinarian evaluates available options and selects treatments based on effectiveness, side effect profiles, and individual patient considerations.

Supportive therapies may accompany cortisone or other corticosteroid treatment to manage side effects or enhance overall care. Gastroprotective medications may be prescribed to reduce risk of gastrointestinal ulceration, particularly with higher doses or concurrent NSAID use. Dietary management may help address increased appetite and prevent excessive weight gain during treatment. Monitoring blood glucose in diabetic or diabetes-prone cats receiving corticosteroids helps detect metabolic changes requiring intervention. Pet owners should discuss any additions or changes to their cat's treatment regimen with the veterinary team to ensure compatibility with cortisone therapy. Substitution of one corticosteroid for another should never be done without veterinary guidance, as different corticosteroids have varying potencies that require appropriate dose adjustments.